OZAWA KEIYA has a total of 12 patent applications. Its first patent ever was published in 2001. It filed its patents most often in EPO (European Patent Office), Australia and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are NVENTA BIOPHARMACEUTICALS CORP, CISTEM BIOTECHNOLOGIES GMBH and ADISTEM LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | Australia | 2 | |
#3 | Canada | 2 | |
#4 | United States | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks | |
#4 | Agriculture |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides | |
#5 | Enzymes | |
#6 | Animal care |
# | Name | Total Patents |
---|---|---|
#1 | Ozawa Keiya | 12 |
#2 | Shimpo Masahisa | 6 |
#3 | Maeda Yoshikazu | 6 |
#4 | Ikeda Uichi | 6 |
#5 | Shimada Kazuyuki | 6 |
#6 | Kume Akihiro | 5 |
#7 | Mizukami Hiroaki | 5 |
#8 | Hanazono Yutaka | 1 |
#9 | Hasegawa Mamoru | 1 |
#10 | Ueda Yasuji | 1 |
Publication | Filing date | Title |
---|---|---|
CA2479996A1 | Compositions for delivering enyzmes involved in acid metabolism using recombinant adeno-associated virus virons (raav virons), and method and use for treating amino acid metabolicdisorders using such raav virons | |
CA2419245A1 | Adeno-associated virus-mediated delivery of angiogenic factors | |
EP1870473A1 | Adeno-associated virus-mediated delivery of angiogenic factors |